These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. The neurotoxicity of the halogenated hydroxyquinolines. A commentary. Oakley GP JAMA; 1973 Jul; 225(4):395-7. PubMed ID: 4270059 [No Abstract] [Full Text] [Related]
26. A neurological evaluation of purported cases of SMON in Sweden. Gilland O Acta Neurol Scand Suppl; 1984; 100():165-9. PubMed ID: 6091395 [TBL] [Abstract][Full Text] [Related]
31. [Subacute myelo-optico-neuropathy following use of large amounts of iodochlorhydroxyquinoline (Enterovioform)]. Bron HL; Korten JJ; Pinckers AJ; Majoor CL Ned Tijdschr Geneeskd; 1972 Sep; 116(36):1615-8. PubMed ID: 4262825 [No Abstract] [Full Text] [Related]
32. [Epidemiology of SMON--our experience with the occurrence in the hospital]. Ando K; Sobue I Shinkei Kenkyu No Shimpo; 1971; 15(2):531-5. PubMed ID: 5106860 [No Abstract] [Full Text] [Related]